These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9557145)

  • 1. The influence of different gases on acoustic properties of a spherosome-based ultrasound contrast agent (BY963). A transcranial Dopplersonography study.
    Seidel G; Beller KD; Aaslid R; Hummel RP; Thibaut U; Vidal-Langwasser M; Kukat B; Kaps M
    J Neuroimaging; 1998 Apr; 8(2):83-7. PubMed ID: 9557145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I: transcranial echo contrast studies in healthy volunteers.
    Kaps M; Schaffer P; Beller KD; Seidel G; Bliesath H; Wurst W
    Stroke; 1995 Nov; 26(11):2048-52. PubMed ID: 7482648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of modified spherosome suspension (BY963) leads to an increase of acoustic impedance in dog brain tissue.
    Seidel G; Beller KD; Kaps M
    J Neuroimaging; 1998 Jul; 8(3):164-8. PubMed ID: 9664853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent opacification of the left ventricle and myocardium with a new echo contrast agent.
    Strauss AL; Beller KD
    Ultrasound Med Biol; 1999 Jun; 25(5):763-9. PubMed ID: 10414894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of Doppler system settings on the clearance kinetics of different ultrasound contrast agents.
    Seidel G; Vidal-Langwasser M; Algermissen C; Gerriets T; Kaps M
    Eur J Ultrasound; 1999 May; 9(2):167-75. PubMed ID: 10413753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of different echo-contrast agents in the cerebral circulation of dogs.
    Seidel G; Beller KD; Kaps M
    Ultrasound Med Biol; 1996; 22(8):1037-42. PubMed ID: 9004427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of transcranial Doppler signal enhancement using a phospholipid-containing echocontrast agent.
    Kaps M; Schaffer P; Beller KD; Seidel G; Bliesath H; Diletti E
    Stroke; 1997 May; 28(5):1006-8. PubMed ID: 9158642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of contrast enhanced transcranial Doppler signal using galactose based echo-contrast agent in dogs.
    Chung W; Choi H; Lee K; Lee H; Choi M; Yoon J
    J Vet Med Sci; 2006 Jun; 68(6):597-601. PubMed ID: 16820717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial Doppler echo contrast studies using different colour processing modes.
    Kaps M; Schaffer P; Beller KD; Seidel G; Wurst W
    Acta Neurol Scand; 1997 Jun; 95(6):358-62. PubMed ID: 9228270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harmonic grey scale imaging of the human brain.
    Seidel G; Greis C; Sonne J; Kaps M
    J Neuroimaging; 1999 Jul; 9(3):171-4. PubMed ID: 10436760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and ultrasound-enhancing potentials of a new sulfur hexafluoride-containing agent in the cerebral circulation.
    Kaps M; Seidel G; Bokor D; Modrau B; Algermissen C
    J Neuroimaging; 1999 Jul; 9(3):150-4. PubMed ID: 10436756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transpulmonary contrast medium enhances the transcranial Doppler signal in humans.
    Ries F; Honisch C; Lambertz M; Schlief R
    Stroke; 1993 Dec; 24(12):1903-9. PubMed ID: 7902620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulated acoustic emission detected by transcranial color doppler ultrasound : a contrast-specific phenomenon useful for the detection of cerebral tissue perfusion.
    Pohl C; Tiemann K; Schlosser T; Becher H
    Stroke; 2000 Jul; 31(7):1661-6. PubMed ID: 10884470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcranial Doppler: Does Addition of Blood to Agitated Saline Affect Sensitivity for Detecting Cardiac Right-to-Left Shunt?
    Mojadidi MK; Zhang L; Chugh Y; Eshtehardi P; Hovnanians N; Gevorgyan R; Mojaddedi S; Nezami N; Zaman MO; Rafique A; Villablanca PA; Tobis JM
    Echocardiography; 2016 Aug; 33(8):1219-27. PubMed ID: 27095475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of echocontrast agent infusion in a dog model.
    Kaps M; Seidel G; Algermissen C; Gerriets T; Broillet A
    J Neuroimaging; 2001 Jul; 11(3):298-302. PubMed ID: 11462298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of regional cerebral blood flow in dogs, with an experimental microbubble-based US contrast agent.
    Greenberg RS; Taylor GA; Stapleton JC; Hillsley CA; Spinak D
    Radiology; 1996 Oct; 201(1):119-23. PubMed ID: 8816531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with echo-enhanced transcranial Doppler and duplex imaging.
    Ries F
    J Neuroimaging; 1997 Apr; 7 Suppl 1():S15-21. PubMed ID: 9128461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound contrast media for neurovascular applications].
    Gahn G; Ackerman RH; Candia MR
    Ultraschall Med; 1997 Jun; 18(3):101-4. PubMed ID: 9340734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of inhaled gases on ultrasound contrast agent longevity in vivo.
    Itani M; Mattrey RF
    Mol Imaging Biol; 2012 Feb; 14(1):40-6. PubMed ID: 21365328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroV Technology to Improve Transcranial Color Coded Doppler Examinations.
    Malferrari G; Pulito G; Pizzini AM; Carraro N; Meneghetti G; Sanzaro E; Prati P; Siniscalchi A; Monaco D
    J Neuroimaging; 2018 Jul; 28(4):350-358. PubMed ID: 29727515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.